Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome

被引:256
作者
Albertine, KH
Soulier, MF
Wang, ZM
Ishizaka, A
Hashimoto, S
Zimmerman, GA
Matthay, MA
Ware, LB
机构
[1] Univ Utah, Dept Pediat, Div Resp Crit Care & Occupat Pulm Med, Salt Lake City, UT 84132 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, Div Crit Care Med, San Francisco, CA 94143 USA
[3] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Nashville, TN USA
[4] Keio Univ, Tokyo Elect Power Hosp, Tokyo, Japan
[5] Kyoto Prefectural Univ Med, Dept Anesthesia & Intens Care, Kyoto, Japan
关键词
D O I
10.1016/S0002-9440(10)64455-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Apoptosis mediated by Fas/Fas ligand (FasL) interaction has been implicated in human disease processes, including pulmonary disorders. However, the role of the Fas/FasL system in acute lung injury (ALI) and in the acute respiratory distress syndrome (ARDS) is poorly defined. Accordingly, we investigated both the soluble and cellular expression of the Fas/FasL system in patients with AIJ or ARDS. The major findings are summarized as follows. First, the soluble expression of the Fas/FasL system was assessed in undiluted pulmonary edema fluid and simultaneous plasma. Pulmonary edema fluid obtained from patients with ALI or ARDS (n = 51) had significantly higher concentrations of both soluble Fas (27 ng/ml; median; P < 0.05) and soluble FasL (0.125 ng/ml; P < 0.05) compared to control patients with hydrostatic pulmonary edema (n = 40; soluble Fas, 12 ng/ml; soluble FasL, 0.080 ng/ml). In addition, the concentrations of both soluble Fas and soluble FasL were significantly higher in the pulmonary edema fluid of the patients with ALI or ARDS compared to simultaneous plasma samples (soluble Fas, 16 ng/ml; soluble FasL, 0.058 ng/ml; P < 0.05), indicating local release in the lung. Higher soluble Fas concentrations were associated with worse clinical outcomes. Second, cellular expression of the Fas/FasL system was assessed by semiquantitative immunofluorescence microscopy in lung tissue obtained at autopsy from a different set of patients. Both Fas and FasL were immunolocalized to a greater extent in the patients who died with ALI or ARDS (n = 10) than in the patients who died without pulmonary disease (n = 10). Both proteins were co-expressed by epithelial cells that lined the alveolar walls, as well as by inflammatory cells and sloughed epithelial cells that were located in the air spaces. Semiquantitative immunohistochemistry showed that markers of apoptosis (terminal dUTP nick-end labeling, caspase-3, Bax, and P53) were more prevalent in alveolar wall cells from the patients who died with ALI or ARDS compared to the patients who died without pulmonary disease. These findings indicate that alveolar epithelial injury in humans with ALI or ARDS is in part associated with local up-regulation of the Fas/FasL system and activation of the apoptotic cascade in the epithelial cells that line the alveolar air spaces.
引用
收藏
页码:1783 / 1796
页数:14
相关论文
共 57 条
  • [21] NEURAL DYSFUNCTION DURING HYPOGLYCEMIA
    KOH, THHG
    AYNSLEYGREEN, A
    TARBIT, M
    EYRE, JA
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (11) : 1353 - 1358
  • [22] NEW SERUM INDICATOR OF INTERSTITIAL PNEUMONITIS ACTIVITY - SIALYLATED CARBOHYDRATE ANTIGEN KL-6
    KOHNO, N
    KYOIZUMI, S
    AWAYA, Y
    FUKUHARA, H
    YAMAKIDO, M
    AKIYAMA, M
    [J]. CHEST, 1989, 96 (01) : 68 - 73
  • [23] KOHNO N, 1988, JPN J CLIN ONCOL, V18, P203
  • [24] Soluble form of Fas and Fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia
    Kuwano, K
    Kawasaki, M
    Maeyama, T
    Hagimoto, N
    Nakamura, N
    Shirakawa, K
    Hara, N
    [J]. CHEST, 2000, 118 (02) : 451 - 458
  • [25] Expression of FasL and Fas protein and their soluble form in patients with hypersensitivity pneumonitis
    Kuwano, K
    Hagimoto, N
    Kawasaki, M
    Nakamura, N
    Shirakawa, K
    Maeyama, T
    Hara, N
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2000, 122 (03) : 209 - 215
  • [26] Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
    Kuwano, K
    Hagimoto, N
    Kawasaki, M
    Yatomi, T
    Nakamura, N
    Nagata, S
    Suda, T
    Kunitake, R
    Maeyama, T
    Miyazaki, H
    Hara, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) : 13 - 19
  • [27] The involvement of Fas-Fas ligand pathway in fibrosing lung diseases
    Kuwano, K
    Miyazaki, H
    Hagimoto, N
    Kawasaki, M
    Fujita, M
    Kunitake, R
    Kaneko, Y
    Hara, N
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (01) : 53 - 60
  • [28] Leukocyte elastase - Physiological functions and role in acute lung injury
    Lee, WL
    Downey, GP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (05) : 896 - 904
  • [29] A NEW SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS-II) BASED ON A EUROPEAN NORTH-AMERICAN MULTICENTER STUDY
    LEGALL, JR
    LEMESHOW, S
    SAULNIER, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (24): : 2957 - 2963
  • [30] Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
    Liles, WC
    Kiener, PA
    Ledbetter, JA
    Aruffo, A
    Klebanoff, SJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 429 - 440